
HB 403 – Louisiana
Status: EnactedYear Introduced: 2023
Link: https://legis.la.gov/legis/BillInfo.aspx?i=244326
Authorizes substitution of certain biosimilar biological products relative to step therapy or fail first protocols
Return to Database Search
© 2018- The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.
Associated Litigation:
No items found